New England Private Wealth Advisors’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-13,181
| Closed | -$199K | – | 120 |
|
|
2019
Q3 | $199K | Buy |
13,181
+129
| +1% | +$1.95K | 0.05% | 160 |
|
|
2019
Q2 | $220K | Buy |
13,052
+116
| +0.9% | +$1.96K | 0.05% | 146 |
|
|
2019
Q1 | $221K | Buy |
12,936
+100
| +0.8% | +$1.71K | 0.06% | 141 |
|
|
2018
Q4 | $194K | Buy |
12,836
+144
| +1% | +$2.18K | 0.06% | 135 |
|
|
2018
Q3 | $260K | Buy |
12,692
+98
| +0.8% | +$2.01K | 0.07% | 119 |
|
|
2018
Q2 | $237K | Buy |
12,594
+100
| +0.8% | +$1.88K | 0.07% | 127 |
|
|
2018
Q1 | $240K | Buy |
12,494
+99
| +0.8% | +$1.9K | 0.07% | 123 |
|
|
2017
Q4 | $244K | Buy |
12,395
+104
| +0.8% | +$2.05K | 0.07% | 122 |
|
|
2017
Q3 | $264K | Buy |
12,291
+89
| +0.7% | +$1.91K | 0.08% | 113 |
|
|
2017
Q2 | $255K | Buy |
+12,202
| New | +$255K | 0.08% | 115 |
|
|
2017
Q1 | – | Sell |
-12,035
| Closed | -$204K | – | 138 |
|
|
2016
Q4 | $204K | Buy |
12,035
+100
| +0.8% | +$1.7K | 0.07% | 115 |
|
|
2016
Q3 | $224K | Hold |
11,935
| – | – | 0.08% | 111 |
|
|
2016
Q2 | $205K | Buy |
11,935
+144
| +1% | +$2.47K | 0.08% | 113 |
|
|
2016
Q1 | $212K | Buy |
11,791
+196
| +2% | +$3.52K | 0.09% | 107 |
|
|
2015
Q4 | $274K | Buy |
+11,595
| New | +$274K | 0.11% | 91 |
|
|
2015
Q1 | – | Sell |
-11,053
| Closed | -$275K | – | 112 |
|
|
2014
Q4 | $275K | Buy |
11,053
+123
| +1% | +$3.06K | 0.11% | 81 |
|
|
2014
Q3 | $241K | Buy |
10,930
+133
| +1% | +$2.93K | 0.1% | 86 |
|
|
2014
Q2 | $225K | Buy |
10,797
+132
| +1% | +$2.75K | 0.09% | 96 |
|
|
2014
Q1 | $232K | Sell |
10,665
-6,162
| -37% | -$134K | 0.1% | 87 |
|
|
2013
Q4 | $344K | Buy |
+16,827
| New | +$344K | 0.16% | 66 |
|